ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC

MLA

Bernier, J., et al. “ARCON: Accelerated Radiotherapy with Carbogen and Nicotinamide in Non Small Cell Lung Cancer: A Phase I/II Study by the EORTC.” Radiotherapy and Oncology, vol. 52, no. 2, Jan. 1999, pp. 149–56. EBSCOhost, https://doi.org/10.1016/S0167-8140(99)00106-1.

APA

Bernier, J., Denekamp, J., Rojas, A., Trovo, M., Horiot, J.-C., Hamers, H., Antognoni, P., Dahl, O., Richaud, P., & Kaanders, J. (1999). ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC. Radiotherapy and Oncology, 52(2), 149–156. https://doi.org/10.1016/S0167-8140(99)00106-1

Chicago

Bernier, J., J. Denekamp, A. Rojas, M. Trovo, J.-C. Horiot, H. Hamers, P. Antognoni, O. Dahl, P. Richaud, and J. Kaanders. 1999. “ARCON: Accelerated Radiotherapy with Carbogen and Nicotinamide in Non Small Cell Lung Cancer: A Phase I/II Study by the EORTC.” Radiotherapy and Oncology 52 (2): 149–56. doi:10.1016/S0167-8140(99)00106-1.